Dr. Noci Deda, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 185 Old Military Rd, Lake Placid, NY 12946 Phone: 518-523-2464 Fax: 518-523-1401 |
News Archive
Genzyme, a subsidiary of sanofi-aventis Group, announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis at the American Academy of Neurology's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
A $1.5 million grant from the National Institutes of Health will advance work by Indiana University researchers that seeks to identify Americans at risk for diabetes and other metabolic disorders based on their exposure to trace minerals in the environment.
When crime lab chemists handle evidence that contains illegal drugs, trace amounts of those drugs are inevitably released into the laboratory environment.
Induced pluripotent stem cells (iPS cells) are truly talented multi-taskers. They can reproduce almost all cell types and thus offer great hope in the fight against diseases like Alzheimer's and Parkinson's. However, it would appear that their use is not entirely without risk: during the reprogramming of body cells into iPS cells, disease-causing mutations can creep into the genetic material.
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
› Verified 8 days ago